Category: Health

  • FG launches ‘1,000 Days of Life’ campaign to improve maternal, child nutrition

    FG launches ‘1,000 Days of Life’ campaign to improve maternal, child nutrition

    ABUJA, Nigeria (NPA) — The Federal Government has launched the 1,000 Days of Life Social and Behaviour Change (SBC) Campaign, a nationwide initiative aimed at improving maternal and child nutrition by promoting optimal breastfeeding and healthy infant feeding practices during the critical period from conception to a child’s second birthday.

    The campaign was unveiled on Monday in Abuja as part of activities marking the 2026 World Breastfeeding Week, themed “Breastfeeding for a Sustainable Start in Life: Strengthen What Works.”

    The initiative, according to the Federal Ministry of Health and Social Welfare, is designed to improve child survival, reduce malnutrition and ensure that every Nigerian child receives the healthiest possible start in life.

    Launching the campaign, the Permanent Secretary of the Federal Ministry of Health and Social Welfare, Daju Kachollom, described breastfeeding as one of the most effective, life-saving and cost-effective interventions for child survival and development.

    “Every child deserves the healthiest possible start to life. Protecting the first 1,000 days is one of the smartest investments we can make for Nigeria’s future, and breastfeeding remains one of the most powerful tools to achieve that,” she said.

    Kachollom cited findings from the 2023/2024 Nigeria Demographic and Health Survey (NDHS), which showed that although about 95 per cent of Nigerian mothers breastfeed, only 36 per cent initiate breastfeeding within the first hour after birth.

    She added that only 29 per cent of infants are exclusively breastfed during their first six months, while just 23 per cent continue breastfeeding up to two years, figures that remain below recommended global standards.

    According to her, the statistics underscore the urgent need to strengthen interventions during the first 1,000 days of life, a period considered critical to a child’s physical and cognitive development.

    The Permanent Secretary identified delayed initiation of breastfeeding, harmful cultural beliefs, inadequate counselling, limited workplace support and the aggressive marketing of breastmilk substitutes as major barriers to optimal breastfeeding practices.

    She said the Federal Government has continued to implement policies and programmes aimed at addressing the challenges.

    These include strengthening the National Maternal, Infant and Young Child Nutrition Strategy, expanding the Baby-Friendly Hospital and Community Initiatives, enforcing the International Code of Marketing of Breastmilk Substitutes, building the capacity of healthcare workers and promoting breastfeeding-friendly workplaces.

    Kachollom explained that the newly launched campaign would mobilise families, communities, healthcare workers and other stakeholders to promote improved maternal nutrition, early initiation of breastfeeding, exclusive breastfeeding for the first six months, appropriate complementary feeding and continued breastfeeding up to two years and beyond.

    She added that the initiative would also encourage greater utilisation of Primary Health Care Centres for maternal and child health services across the country.

    Also speaking, the Director of Nutrition at the ministry, Mrs Olufunmilola Adegbite, described the campaign as a strategic investment in Nigeria’s human capital, stressing that improving maternal and child nutrition is essential to achieving sustainable national development.

    Development partners, including the United Nations Children’s Fund (UNICEF), reaffirmed their commitment to supporting the Federal Government through technical assistance, advocacy and community-based behaviour change interventions.

    Delivering a goodwill message on behalf of Vice President Kashim Shettima, Mrs Uju Rochas-Anwukah called on stakeholders to ensure the campaign reaches communities in all 774 local government areas of the country.

    She described breastfeeding as a national investment capable of improving child health outcomes and strengthening Nigeria’s future.

    The Federal Ministry of Health and Social Welfare reaffirmed its commitment to working with state governments, development partners, healthcare professionals, employers, communities and families to strengthen breastfeeding support systems, improve maternal and child nutrition and ensure that every Nigerian child benefits from quality care during the first 1,000 days of life.

  • Africa CDC welcomes new HIV prevention manufacturing partnerships across Africa

    Africa CDC welcomes new HIV prevention manufacturing partnerships across Africa

    ADDIS ABABA, Ethiopia (NPA) — The Africa Centres for Disease Control and Prevention (Africa CDC) has welcomed new voluntary licensing agreements between global pharmaceutical company MSD and three African manufacturers, describing the initiative as a major step towards strengthening the continent’s pharmaceutical manufacturing capacity and improving access to innovative healthcare.

    The announcement was made on Wednesday in Addis Ababa, where Africa CDC said the partnerships align with its Health Security and Sovereignty Agenda by advancing innovation across Africa’s pharmaceutical value chain.

    According to Africa CDC, the agreements relate to MK-8527, an investigational once-monthly oral HIV pre-exposure prophylaxis (PrEP) candidate currently under development.

    The agency said the initiative links Africa’s growing clinical research ecosystem with regional manufacturing to promote equitable access to high-quality health innovations across the continent.

    Under the agreements, MSD has partnered with Aspen Pharmacare of South Africa, Quality Chemicals Industries Limited of Uganda and Universal Corporation Limited of Kenya.

    Welcoming the collaboration, South African President Cyril Ramaphosa described the partnership as a vote of confidence in Africa’s pharmaceutical capabilities.

    “This partnership demonstrates confidence not only in South Africa’s capabilities, but in Africa’s ability to manufacture the medicines of the future,” Ramaphosa said.

    Also commenting on the development, Africa CDC Director-General, Dr Jean Kaseya, said the agreements represent a new approach to global health innovation by positioning African countries as contributors to research, manufacturing and access to new medicines.

    “This is more than a manufacturing announcement. It demonstrates a new partnership model in which African countries help generate scientific evidence, prepare to manufacture innovative products and, ultimately, improve access for African patients,” Kaseya said.

    He reaffirmed Africa CDC’s commitment to supporting member states, regulators, manufacturers and development partners in strengthening manufacturing readiness and expanding equitable access to innovative medicines across the continent.

    The agency said it would also support the rollout of licensed products through the African Pooled Procurement Mechanism, aimed at improving access to essential medicines for African countries.

    Africa CDC is the African Union’s specialised public health agency, established to strengthen health systems, improve disease surveillance and enhance emergency preparedness and response across AU member states.

  • Nigeria targets 30% reduction in cancer burden by 2030 under new National Plan

    Nigeria targets 30% reduction in cancer burden by 2030 under new National Plan

    ABUJA, Nigeria (NPA) — The Federal Government has intensified the implementation of the National Cancer Control Plan (NCCP) 2026–2030, targeting a 30 per cent reduction in Nigeria’s cancer burden by 2030 while calling for stronger African collaboration to improve cancer prevention, research and access to quality treatment.

    The Minister of State for Health and Social Welfare, Dr Iziaq Salako, disclosed this at the African Organisation for Research and Training in Cancer (AORTIC) Best of ASCO Africa 2026 conference in Abuja.

    The regional scientific meeting brings together oncology professionals from across Africa to review and adapt the latest clinical advances presented at the American Society of Clinical Oncology (ASCO) Annual Meeting.

    According to Salako, the renewed implementation of the National Cancer Control Plan reflects the Federal Government’s commitment under President Bola Tinubu’s Renewed Hope Agenda to strengthen the fight against non-communicable diseases.

    He noted that cancer has become one of Africa’s leading public health challenges, citing recent statistics showing that the continent recorded more than 1.18 million new cancer cases and over 721,000 cancer-related deaths in 2024.

    The minister said cancer now claims more lives across Africa than HIV/AIDS, malaria and tuberculosis combined.

    He further disclosed that Nigeria accounts for approximately 10.5 per cent of Africa’s total cancer burden, making it one of the continent’s three most affected countries alongside Egypt and South Africa.

    According to Salako, the National Cancer Control Plan 2026–2030 provides a comprehensive framework for improving cancer prevention, early detection, diagnosis, treatment, survivorship, research, workforce development, data systems, artificial intelligence, partnerships and resource mobilisation.

    “The National Cancer Control Plan provides a comprehensive roadmap for strengthening prevention, early detection, diagnosis, treatment, survivorship, research, workforce development, data systems, artificial intelligence, partnerships and resource mobilisation to improve cancer outcomes nationwide,” he said.

    To ensure effective implementation, the minister announced that the Federal Government has inaugurated a multi-sectoral National Technical Working Group comprising clinicians, researchers, cancer survivors, civil society organisations, development partners and private sector representatives.

    He explained that the committee would adopt an implementation science approach aimed at translating government policy into measurable improvements in cancer care and patient outcomes.

    Salako also challenged African scientists and oncology professionals to generate more research based on African populations instead of relying solely on studies conducted elsewhere.

    He stressed that locally generated evidence would help develop treatment approaches better suited to the continent’s unique healthcare realities.

    Calling for what he described as “Cancer Care Pan-Africanism,” the minister urged African governments to deepen cooperation in cancer research, innovation, workforce development and access to affordable treatment.

    According to him, healthcare should occupy a more prominent position in continental cooperation alongside political, economic and security issues.

    He commended the African Organisation for Research and Training in Cancer (AORTIC), the American Society of Clinical Oncology (ASCO) and other partners for organising the conference, describing it as an important platform for adapting global cancer treatment advances to African healthcare systems.

    Salako reaffirmed Nigeria’s commitment to providing leadership in cancer education, research, advocacy and strategic partnerships aimed at reducing cancer-related deaths, improving patients’ quality of life and building resilient cancer care systems across Africa.

  • JUST IN: NAFDAC DG Mojisola Adeyeye receives African Leadership Award in London

    JUST IN: NAFDAC DG Mojisola Adeyeye receives African Leadership Award in London

    LONDON, United Kingdom (NPA) — Director-General of the National Agency for Food and Drug Administration and Control (NAFDAC), Prof. Mojisola Adeyeye, has received the Special African Leadership Commendation Award at the 16th African Business Leadership Awards (ABLA) held at the House of Lords, Palace of Westminster, London.

    The award, presented by the African Leadership Organisation (ALO), recognises her leadership in transforming NAFDAC through institutional reforms, regulatory excellence and digital innovation.

    According to NAFDAC, the recognition followed an assessment of the agency’s performance since Adeyeye assumed office in November 2017.

    The agency said her administration eliminated inherited debts, modernised laboratories and regulatory infrastructure, digitised about 90 per cent of its regulatory processes, strengthened quality management systems and secured ISO 9001 certification.

    NAFDAC also attained the World Health Organisation (WHO) Global Benchmarking Maturity Level 3 in 2022 and successfully retained the status following a re-benchmarking exercise in 2025.

    The agency further highlighted milestones, including the WHO prequalification of its Central Drug Laboratory, Nigeria’s Pre-Accession Pre-Applicant status in the Pharmaceutical Inspection Co-operation Scheme (PIC/S), and membership of the International Council for Harmonisation (ICH).

    NAFDAC said Adeyeye’s reforms have also strengthened local pharmaceutical manufacturing through the implementation of the Five Plus Five Regulatory Directive, which promotes domestic drug production and reduces reliance on imported medicines.

    Speaking after receiving the award, Adeyeye dedicated the honour to NAFDAC staff, describing it as recognition of their professionalism and commitment to safeguarding public health.

    She reaffirmed the agency’s commitment to strengthening Nigeria’s regulatory systems and advancing internationally recognised standards to support healthcare delivery and economic development.

    The award ceremony formed part of the two-day African Business Leadership Awards programme, themed “From Vision to Velocity: Driving Africa’s Next Wave of Growth and Leadership.”

    Adeyeye also delivered a keynote address on innovation, digitisation and regulatory excellence, highlighting the role of effective medicines regulation in advancing public health and economic development across Africa.

  • WHO declares Hantavirus outbreak over after 13 cases, three deaths

    WHO declares Hantavirus outbreak over after 13 cases, three deaths

    GENEVA, Switzerland (NPA) — The World Health Organisation (WHO) has officially declared the hantavirus outbreak linked to the cruise ship MV Hondius over, following the successful completion of quarantine by the final identified contact and the absence of new infections since May 25.

    In a statement issued on Thursday, the UN health agency said the last person exposed to the virus had completed the required quarantine period, tested negative, and safely returned home.

    “Today, the final contact of a person exposed to hantavirus on the cruise ship MV Hondius completed their quarantine period, tested negative and returned home,” WHO said.

    “No further cases have been reported since the 25th of May. We are therefore very pleased to say that WHO considers the outbreak over.”

    According to the organisation, the outbreak resulted in a total of 13 confirmed cases, including three deaths.

    WHO disclosed that health authorities across 33 countries and territories identified and monitored more than 650 contacts during the international response to contain the spread of the disease.

    Although the outbreak has been declared over, the agency said efforts to better understand hantavirus and strengthen global preparedness would continue.

    WHO announced that it is coordinating an international scientific study involving 21 countries to improve knowledge of how the disease develops and to support the development of improved diagnostics, treatments and vaccines for future outbreaks.

    The organisation also expressed appreciation to countries that collaborated in the international response in line with the International Health Regulations.

    It specifically thanked Argentina, Cabo Verde, Chile, the Netherlands, South Africa, the United Kingdom and Spain for their support.

    WHO singled out Spain for its role in facilitating the safe disembarkation and repatriation of passengers and crew in Tenerife during the emergency.

    The agency said the international cooperation demonstrated throughout the response underscores the importance of coordinated global action in managing cross-border public health emergencies.

  • Tinubu establishes National Health Technology Office, appoints Obi Adigwe as coordinator

    Tinubu establishes National Health Technology Office, appoints Obi Adigwe as coordinator

    ABUJA, Nigeria (NPA) — President Bola Tinubu has approved the establishment of the National Health Technology and Data Analytics Office (NHTDAO) to drive Nigeria’s digital health agenda and appointed Dr Obi Adigwe as its pioneer National Coordinator.

    According to a statement issued on Friday by the President’s Special Adviser on Information and Strategy, Mr Bayo Onanuga, the new office will operate under the Office of the Coordinating Minister of Health and Social Welfare.

    The presidency said the NHTDAO will serve as the country’s central platform for coordinating digital health initiatives, strengthening collaboration across the public and private health sectors, and implementing the National Digital Health Architecture approved by the National Council on Health in November 2025.

    It noted that the office would complement, rather than replace, the statutory responsibilities of existing government agencies by harmonising digital health standards and promoting interoperability across Nigeria’s healthcare system.

    Adigwe, who currently serves as Director-General of the National Institute for Pharmaceutical Research and Development (NIPRD), was credited with leading several major scientific and technology-driven initiatives.

    According to the statement, he coordinated projects including a ¥300 million nanotechnology grant, an Afreximbank-supported project for Africa’s first Active Pharmaceutical Ingredients (API) Training Facility, and the roadmap that secured an €18 million European Union grant for health research. He also gained international recognition during the COVID-19 pandemic for leading what the presidency described as the world’s first scientific analysis debunking claims surrounding the COVID Organics preparation.

    The presidency also announced the constitution of a Steering Committee to provide strategic direction for the new office.

    The committee will be co-chaired by the Coordinating Minister of Health and Social Welfare, Professor Muhammad Ali Pate, and Chairman of the Nigerian Economic Summit Group, Mr Olaniyi Yusuf.

    Other members include the Minister of State for Health and Social Welfare, Dr Iziaq Adekunle Salako, senior officials of the Federal Ministry of Health and Social Welfare, representatives of key health and technology agencies, state commissioners of health, and industry stakeholders.

    President Tinubu expressed confidence that the NHTDAO would accelerate Nigeria’s transition to a secure, interoperable and data-driven healthcare system capable of improving health outcomes nationwide, in line with the Renewed Hope Agenda of his administration.

  • Ebola Task Force moves to prevent virus importation into Nigeria

    Ebola Task Force moves to prevent virus importation into Nigeria

    ABUJA, Nigeria (NPA) — The Presidential Task Force (PTF) on Ebola Virus Disease (EVD) Preparedness and Emerging Public Health Threats has urged all stakeholders to intensify efforts to prevent the importation of the virus into Nigeria amid outbreaks in parts of East and Central Africa.

    The Chairman of the task force and Chief of Staff to the President, Mr Femi Gbajabiamila, made the call on Thursday in Abuja during the inauguration of the committee.

    Gbajabiamila said the immediate priority of the task force was to closely monitor the Ebola outbreaks in the Democratic Republic of Congo (DRC), Uganda and neighbouring countries while strengthening measures to prevent the disease from entering Nigeria.

    “Our first task is to address the Ebola outbreak in DRC, Uganda and neighbouring countries and prevent the importation of the virus into Nigeria,” he said.

    “We want to ensure that Nigeria is not caught unprepared for the task ahead. We have been down this road before and we intend to address whatever shortcomings there may have been in the past.”

    According to him, the task force will serve as the principal decision-making body on matters requiring executive or presidential approval, including flight restrictions, port closures, quarantine directives and emergency funding releases.

    He said the committee would coordinate Nigeria’s whole-of-government response to Ebola and other emerging public health threats.

    The Chief of Staff explained that the task force would receive and review reports from the Nigeria Centre for Disease Control and Prevention (NCDC)-led Emergency Operations Centre and other relevant subcommittees, while escalating recommendations requiring presidential approval.

    He added that the committee would oversee the implementation and funding of the National Ebola Virus Disease Preparedness and Response Plan.

    Other responsibilities include managing Nigeria’s international obligations, coordinating public communication strategies and determining escalation measures in the event of confirmed Ebola cases in neighbouring countries or within Nigeria.

    “The task force will ensure timely public messaging through the Ministry of Information and the NCDC and provide regular reports to President Bola Tinubu as may be required,” Gbajabiamila said.

    He noted that the committee would review and approve subcommittee recommendations before implementation or public communication and could be dissolved or reconstituted once the threat had been contained or escalated into a full national emergency.

    The task force is expected to meet every two months or as circumstances require.

    Earlier, the Director-General of the NCDC, Dr Olajide Idris, disclosed that the agency had already activated several preparedness measures, including strengthening disease surveillance systems at international airports and other entry points.

    According to him, surveillance structures have been activated at Lagos and other international airports, while coordination mechanisms have been established between airport authorities and state governments.

    “The focus is to be prepared. We do not have any Ebola case in Nigeria at the moment, but we must ensure that the virus does not enter the country,” Idris said.

    “However, if a case slips through, we must be fully prepared nationally to identify it quickly and respond effectively.”

    He added that special attention was also being given to Nigeria’s land borders to ensure comprehensive surveillance beyond airports.

    The 18-member task force is chaired by Gbajabiamila, while the NCDC Director-General (Technical) serves as Vice Chairman.

    Members include the Ministers of Aviation, Interior, Finance, Information and State for Foreign Affairs, as well as representatives of the Ministry of Health, the Presidency, the Federal Airports Authority of Nigeria (FAAN), and state commissioners for health from Lagos, Kano, Rivers and Enugu states.

    Also represented on the committee are the World Health Organisation (WHO), the Association of Public Health Physicians of Nigeria (APHPN), and the DRASA Health Trust.

    President Bola Tinubu recently approved the establishment of the task force and authorised the release of N10 billion to support emergency preparedness efforts against Ebola and other emerging public health threats.

  • Lagos launches “Operation Bio‑Shield” to strengthen Ebola preparedness

    Lagos launches “Operation Bio‑Shield” to strengthen Ebola preparedness

    LAGOS, Nigeria (NPA) — The Lagos State Government has launched a statewide public awareness campaign tagged “Operation Lagos Bio‑Shield” to reinforce preparedness against the Ebola Virus Disease (EVD) amid ongoing outbreaks in parts of East and Central Africa.

    Announcing the initiative on Saturday, the State Commissioner for Health, Prof. Akin Abayomi, reassured residents that “there are currently no confirmed cases of Ebola Virus Disease in Lagos State or anywhere in Nigeria.” He explained that the campaign was not a reaction to any crisis but a proactive measure to strengthen public awareness and prevention.

    “This campaign is not a response to a crisis. It is a proactive measure to strengthen public awareness, preparedness, and prevention,” Abayomi said, emphasizing the government’s commitment to safeguarding public health through early action and strategic communication.

    The Commissioner disclosed that the current outbreak in parts of the Democratic Republic of Congo and Uganda involves the Bundibugyo strain of the virus, for which no widely available vaccine or specific antiviral treatment exists. He stressed that “prevention, early detection, rapid isolation, and supportive medical care remain our most effective tools.”

    Abayomi clarified that Ebola is not transmitted through casual contact, but through direct contact with blood, bodily fluids, or contaminated materials of an infected person. He urged residents to rely only on verified information to avoid panic and stigma.

    “As Nigeria’s commercial capital and a major regional transport hub, Lagos maintains extensive air, land, and maritime connections with the rest of Africa and the world,” he noted, adding that both federal and state authorities are strengthening surveillance and screening at all points of entry.

    Over the coming weeks, the Ministry of Health will intensify public enlightenment through education campaigns on Ebola prevention, symptoms, and reporting channels across homes, schools, workplaces, and communities.

    Residents returning from affected countries who develop symptoms such as fever, weakness, vomiting, diarrhoea, or unexplained bleeding are advised to contact emergency lines while avoiding unnecessary contact with others.

    Recalling Lagos’ successful containment of Ebola in 2014, Abayomi expressed confidence in the State’s readiness:

    “Through strong leadership, effective surveillance, rapid response, and the collective efforts of healthcare workers and residents, our State successfully contained Ebola and protected millions of lives. Today, we remain prepared, vigilant, and committed to safeguarding the health of every Lagosian. Together, we will keep Lagos safe,” he said.

  • FG launches healthcare Electrification Marketplace

    FG launches healthcare Electrification Marketplace

    LAGOS, Nigeria (NPA) — The Federal Government has unveiled a landmark investment-driven framework to accelerate the electrification of healthcare facilities nationwide through sustainable private sector partnerships under the Nigeria Power for Health Initiative (NPHI).

    Speaking at the National Healthcare Electrification Investors Matchmaking Forum in Lagos on Monday, the Honourable Minister of State for Health and Social Welfare, Dr. Iziaq Adekunle Salako, described the initiative as a major milestone in implementing resolutions from the National Stakeholders’ Dialogue on Power in the Health Sector.

    He emphasized that reliable electricity is a critical enabler of quality healthcare delivery, powering operating theatres, vaccine cold chains, incubators, diagnostics, oxygen systems, digital health technologies, and emergency services.

    Dr. Salako explained that the NPHI introduces a shift from traditional donor-funded projects to a sustainable Energy-as-a-Service (EaaS) model. Under this framework, specialised energy service providers will finance, deploy, operate, and maintain reliable energy systems for healthcare facilities, allowing hospitals to focus on their core mandate of delivering care.

    The initiative is anchored on three pillars: blended financing, institutional readiness, and national scalability. With government commitment, development finance, climate finance, and private sector investment, the framework seeks to unlock large-scale deployment of sustainable energy solutions across Nigeria’s health sector. While the current phase focuses on federal tertiary institutions, the long-term vision extends to primary, secondary, and private facilities.

    To drive implementation, the government has established a governance structure comprising an Inter-Ministerial Steering Committee, a 24-member Inter-Agency Technical Committee, Facility Energy Management Teams, and a dedicated Project Secretariat within the Federal Ministry of Health and Social Welfare.

    The Minister highlighted recent efforts to strengthen investment readiness, including specialised training for hospital finance directors in energy economics, project finance, and investor engagement. He commended the United Kingdom Partnership for Accelerating Climate Transitions (UK PACT) and Landell Mills International for their strategic support in developing the framework.

    Addressing investors, financiers, and energy developers, Dr. Salako called for stronger collaboration: “This is the beginning of a marketplace where ideas become projects, projects become investments, and investments become reliable electricity for healthcare facilities across Nigeria.”

    The Federal Ministry reaffirmed its commitment to working with public and private partners to sustainably power healthcare facilities and strengthen health outcomes for all Nigerians.

  • JUST IN: US intel chief reveals evidence on American-funded biolabs in 30+ countries with dangerous pathogens

    JUST IN: US intel chief reveals evidence on American-funded biolabs in 30+ countries with dangerous pathogens

    WASHINGTON, D.C. (NPA) — United States Director of National Intelligence (DNI) Tulsi Gabbard has disclosed newly declassified evidence indicating that the U.S. government has funded more than 120 biological laboratories across over 30 countries.

    According to Gabbard, the disclosure follows months of reviews of Intelligence Community records and holdings. The laboratories reportedly include facilities in Ukraine, some of which were considered vulnerable to compromise due to the ongoing Russia-Ukraine conflict.

    She said previous intelligence assessments had warned that at least one U.S.-funded laboratory in Ukraine likely housed dangerous pathogens and faced risks of attack, seizure, or damage amid the war.

    The newly declassified documents, which have been made public, provide details on the existence, locations, history, and funding of the laboratories.

    Gabbard alleged that information regarding the full scope of the programme had been withheld from the American public for years, claiming that concerns raised about the facilities were often dismissed and those making such claims were accused of spreading foreign propaganda.

    According to the DNI, many of the laboratories either currently engage or have previously engaged in research involving hazardous and highly contagious pathogens. She further claimed that some facilities conducted gain-of-function research with limited public visibility and oversight.

    The disclosure comes more than a year after U.S. President Donald Trump signed Executive Order 14292 on May 25, 2025, aimed at ending federal funding for gain-of-function research globally.

    Speaking on the issue, Gabbard criticised what she described as efforts by some politicians, health officials and members of the previous administration to downplay or deny the existence of U.S.-funded biolaboratories abroad.

    “Despite the obvious potential for catastrophic global impact research on dangerous pathogens in biolabs can have, politicians, so-called health professionals like Dr Fauci, and entities within the Biden administration’s national security team lied to the American people about the existence of U.S.-funded and supported biolabs, and threatened those who attempted to expose the truth,” Gabbard said.

    She added that the Office of the Director of National Intelligence (ODNI) would continue working with relevant government agencies to identify the locations of the laboratories, determine the pathogens they contain, and support efforts to end what she described as dangerous gain-of-function research.

    Gabbard also announced new guidance directing the Intelligence Community to intensify information gathering on overseas biological laboratories and related facilities.

    According to her, the directive has already yielded additional information on clinical trials reportedly being conducted at some of the facilities, raising what she described as significant ethical, financial and national security concerns.